Logo image of NOV

NOV INC (NOV) Stock Fundamental Analysis

NYSE:NOV - New York Stock Exchange, Inc. - US62955J1034 - Common Stock - Currency: USD

14.4  0 (0%)

After market: 14.4 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to NOV. NOV was compared to 58 industry peers in the Energy Equipment & Services industry. NOV has an average financial health and profitability rating. NOV may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make NOV suitable for value investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year NOV was profitable.
In the past year NOV had a positive cash flow from operations.
In multiple years NOV reported negative net income over the last 5 years.
Of the past 5 years NOV 4 years had a positive operating cash flow.
NOV Yearly Net Income VS EBIT VS OCF VS FCFNOV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2B -4B -6B

1.2 Ratios

NOV's Return On Assets of 9.39% is fine compared to the rest of the industry. NOV outperforms 79.31% of its industry peers.
Looking at the Return On Equity, with a value of 16.60%, NOV is in the better half of the industry, outperforming 75.86% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 5.93%, NOV is in line with its industry, outperforming 44.83% of the companies in the same industry.
Industry RankSector Rank
ROA 9.39%
ROE 16.6%
ROIC 5.93%
ROA(3y)2.57%
ROA(5y)-12.85%
ROE(3y)4.71%
ROE(5y)-22.6%
ROIC(3y)N/A
ROIC(5y)N/A
NOV Yearly ROA, ROE, ROICNOV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40 -60

1.3 Margins

Looking at the Profit Margin, with a value of 12.05%, NOV is in the better half of the industry, outperforming 75.86% of the companies in the same industry.
Looking at the Operating Margin, with a value of 9.32%, NOV is in line with its industry, outperforming 55.17% of the companies in the same industry.
NOV's Operating Margin has improved in the last couple of years.
NOV's Gross Margin of 22.62% is in line compared to the rest of the industry. NOV outperforms 43.10% of its industry peers.
NOV's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.32%
PM (TTM) 12.05%
GM 22.62%
OM growth 3YN/A
OM growth 5Y24.89%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y44.17%
GM growth 5Y4.57%
NOV Yearly Profit, Operating, Gross MarginsNOV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NOV is destroying value.
Compared to 1 year ago, NOV has more shares outstanding
NOV has more shares outstanding than it did 5 years ago.
NOV has a better debt/assets ratio than last year.
NOV Yearly Shares OutstandingNOV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M
NOV Yearly Total Debt VS Total AssetsNOV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B 25B

2.2 Solvency

NOV has an Altman-Z score of 1.98. This is not the best score and indicates that NOV is in the grey zone with still only limited risk for bankruptcy at the moment.
NOV has a Altman-Z score (1.98) which is comparable to the rest of the industry.
NOV has a debt to FCF ratio of 2.55. This is a good value and a sign of high solvency as NOV would need 2.55 years to pay back of all of its debts.
NOV has a better Debt to FCF ratio (2.55) than 68.97% of its industry peers.
A Debt/Equity ratio of 0.30 indicates that NOV is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.30, NOV is in line with its industry, outperforming 58.62% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.55
Altman-Z 1.98
ROIC/WACC0.73
WACC8.12%
NOV Yearly LT Debt VS Equity VS FCFNOV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B 10B 15B

2.3 Liquidity

NOV has a Current Ratio of 2.57. This indicates that NOV is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.57, NOV is in the better half of the industry, outperforming 75.86% of the companies in the same industry.
A Quick Ratio of 1.65 indicates that NOV should not have too much problems paying its short term obligations.
The Quick ratio of NOV (1.65) is better than 67.24% of its industry peers.
Industry RankSector Rank
Current Ratio 2.57
Quick Ratio 1.65
NOV Yearly Current Assets VS Current LiabilitesNOV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B 10B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 17.46% over the past year.
The Earnings Per Share has been growing by 62.19% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 7.12% in the past year.
NOV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.31% yearly.
EPS 1Y (TTM)17.46%
EPS 3Y62.19%
EPS 5YN/A
EPS Q2Q%13.79%
Revenue 1Y (TTM)7.12%
Revenue growth 3Y12.12%
Revenue growth 5Y0.31%
Sales Q2Q%0.27%

3.2 Future

NOV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.05% yearly.
NOV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.83% yearly.
EPS Next Y18.92%
EPS Next 2Y10.92%
EPS Next 3Y10.26%
EPS Next 5Y11.05%
Revenue Next Year3.69%
Revenue Next 2Y2.41%
Revenue Next 3Y2.82%
Revenue Next 5Y3.83%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NOV Yearly Revenue VS EstimatesNOV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B
NOV Yearly EPS VS EstimatesNOV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 9.73, the valuation of NOV can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of NOV indicates a rather cheap valuation: NOV is cheaper than 84.48% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.28, NOV is valued rather cheaply.
The Price/Forward Earnings ratio is 9.14, which indicates a very decent valuation of NOV.
NOV's Price/Forward Earnings ratio is rather cheap when compared to the industry. NOV is cheaper than 89.66% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 91.29. NOV is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.73
Fwd PE 9.14
NOV Price Earnings VS Forward Price EarningsNOV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as NOV.
Based on the Price/Free Cash Flow ratio, NOV is valued cheaply inside the industry as 84.48% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.17
EV/EBITDA 5.68
NOV Per share dataNOV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

NOV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.51
PEG (5Y)N/A
EPS Next 2Y10.92%
EPS Next 3Y10.26%

6

5. Dividend

5.1 Amount

NOV has a Yearly Dividend Yield of 1.85%. Purely for dividend investing, there may be better candidates out there.
NOV's Dividend Yield is a higher than the industry average which is at 3.31.
NOV's Dividend Yield is comparable with the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 1.85%

5.2 History

The dividend of NOV has a limited annual growth rate of 0.16%.
NOV has been paying a dividend for at least 10 years, so it has a reliable track record.
NOV has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.16%
Div Incr Years1
Div Non Decr Years4
NOV Yearly Dividends per shareNOV Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5

5.3 Sustainability

9.13% of the earnings are spent on dividend by NOV. This is a low number and sustainable payout ratio.
The dividend of NOV is growing, but earnings are growing more, so the dividend growth is sustainable.
DP9.13%
EPS Next 2Y10.92%
EPS Next 3Y10.26%
NOV Yearly Income VS Free CF VS DividendNOV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2B -4B -6B
NOV Dividend Payout.NOV Dividend Payout, showing the Payout Ratio.NOV Dividend Payout.PayoutRetained Earnings

NOV INC

NYSE:NOV (1/29/2025, 8:04:01 PM)

After market: 14.4 0 (0%)

14.4

0 (0%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)10-24 2024-10-24/amc
Earnings (Next)02-04 2025-02-04/amc
Inst Owners100.49%
Inst Owner Change3.79%
Ins Owners0.63%
Ins Owner Change-4.04%
Market Cap5.60B
Analysts71.72
Price Target20.35 (41.32%)
Short Float %5.35%
Short Ratio5.19
Dividend
Industry RankSector Rank
Dividend Yield 1.85%
Yearly Dividend0.2
Dividend Growth(5Y)0.16%
DP9.13%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)26.64%
Min EPS beat(2)-9.94%
Max EPS beat(2)63.22%
EPS beat(4)2
Avg EPS beat(4)7.47%
Min EPS beat(4)-33.06%
Max EPS beat(4)63.22%
EPS beat(8)5
Avg EPS beat(8)12.04%
EPS beat(12)7
Avg EPS beat(12)37.9%
EPS beat(16)8
Avg EPS beat(16)24.76%
Revenue beat(2)1
Avg Revenue beat(2)-1.27%
Min Revenue beat(2)-2.58%
Max Revenue beat(2)0.05%
Revenue beat(4)3
Avg Revenue beat(4)0.26%
Min Revenue beat(4)-2.58%
Max Revenue beat(4)2.63%
Revenue beat(8)5
Avg Revenue beat(8)0.85%
Revenue beat(12)9
Avg Revenue beat(12)1.43%
Revenue beat(16)10
Avg Revenue beat(16)0.49%
PT rev (1m)-2.66%
PT rev (3m)-9.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-13.9%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.36%
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)-2.13%
Valuation
Industry RankSector Rank
PE 9.73
Fwd PE 9.14
P/S 0.63
P/FCF 7.17
P/OCF 5.14
P/B 0.87
P/tB 1.29
EV/EBITDA 5.68
EPS(TTM)1.48
EY10.28%
EPS(NY)1.57
Fwd EY10.94%
FCF(TTM)2.01
FCFY13.94%
OCF(TTM)2.8
OCFY19.45%
SpS22.89
BVpS16.61
TBVpS11.2
PEG (NY)0.51
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.39%
ROE 16.6%
ROCE 9.1%
ROIC 5.93%
ROICexc 6.64%
ROICexgc 8.96%
OM 9.32%
PM (TTM) 12.05%
GM 22.62%
FCFM 8.77%
ROA(3y)2.57%
ROA(5y)-12.85%
ROE(3y)4.71%
ROE(5y)-22.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y28.09%
ROICexc growth 3YN/A
ROICexc growth 5Y43.79%
OM growth 3YN/A
OM growth 5Y24.89%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y44.17%
GM growth 5Y4.57%
F-Score7
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.55
Debt/EBITDA 1.66
Cap/Depr 93.07%
Cap/Sales 3.47%
Interest Coverage 9.43
Cash Conversion 93.8%
Profit Quality 72.79%
Current Ratio 2.57
Quick Ratio 1.65
Altman-Z 1.98
F-Score7
WACC8.12%
ROIC/WACC0.73
Cap/Depr(3y)76.83%
Cap/Depr(5y)67.68%
Cap/Sales(3y)3.3%
Cap/Sales(5y)3.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.46%
EPS 3Y62.19%
EPS 5YN/A
EPS Q2Q%13.79%
EPS Next Y18.92%
EPS Next 2Y10.92%
EPS Next 3Y10.26%
EPS Next 5Y11.05%
Revenue 1Y (TTM)7.12%
Revenue growth 3Y12.12%
Revenue growth 5Y0.31%
Sales Q2Q%0.27%
Revenue Next Year3.69%
Revenue Next 2Y2.41%
Revenue Next 3Y2.82%
Revenue Next 5Y3.83%
EBIT growth 1Y27.3%
EBIT growth 3YN/A
EBIT growth 5Y25.27%
EBIT Next Year55.03%
EBIT Next 3Y20.67%
EBIT Next 5Y15.11%
FCF growth 1Y253.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y467%
OCF growth 3Y-46.35%
OCF growth 5Y-22.79%